1. A phase 1, open‐label, dose‐escalation study of pralatrexate in combination with bortezomib in patients with relapsed/refractory multiple myeloma. (4th April 2016) Authors: Dunn, Tamara J.; Dinner, Shira; Price, Elizabeth; Coutré, Steven E.; Gotlib, Jason; Hao, Ying; Berube, Caroline; Medeiros, Bruno C.; Liedtke, Michaela Journal: British journal of haematology Issue: Volume 173:Number 2(2016) Page Start: 253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase I study of an agonist anti-CD27 human antibody (CDX-1127) in patients with advanced hematologic malignancies or solid tumors. (7th November 2013) Authors: Ansell, Stephen; Northfelt, Donald; Flinn, Ian; Burris, Howard; Dinner, Shira; Villalobos, Victor; Sikic, Branimir; Pilja, Lana; Yellin, Michael; Keler, Tibor; Davis, Thomas Journal: Journal for immunotherapy of cancer Issue: Volume 1(2013)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AL amyloidosis or multiple myeloma? An important distinction – response to Falk. (17th December 2013) Authors: Dinner, Shira; Liedtke, Michaela Journal: British journal of haematology Issue: Volume 164:Number 5(2014:Mar.) Page Start: 749 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Current therapy and novel agents for relapsed or refractory acute lymphoblastic leukemia. Issue 8 (August 2014) Authors: Dinner, Shira; Lee, Daniel; Liedtke, Michaela Journal: Leukemia & lymphoma Issue: Volume 55:Issue 8(2014:Aug.) Page Start: 1715 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Diagnostic and therapeutic implications of genetic heterogeneity in myeloid neoplasms uncovered by comprehensive mutational analysis. (2017) Authors: Choi, Sarah M.; Goldenson, Ben; Peterson, Lo Ann; Dinner, Shira; Stein, Brady L.; Behdad, Amir Journal: Leukemia research reports Issue: Volume 8(2017) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Disparities in receiving disease‐directed therapy, allogeneic stem cell transplantation in non‐Hispanic Black patients with TP53‐mutated acute myeloid leukemia. Issue 6 (21st December 2022) Authors: Badar, Talha; Litzow, Mark R.; Shallis, Rory M.; Patel, Anand; Saliba, Antoine N.; Burkart, Madelyn; Bewersdorf, Jan P.; Stahl, Maximilian; De Camargo Correia, Guilherme Sacchi; Guru Murthy, Guru Subramanian; Abaza, Yasmin; Duvall, Adam; Bradshaw, Danielle; Kota, Vamsi; Dinner, Shira; Goldberg, A... Journal: Cancer Issue: Volume 129:Issue 6(2023) Page Start: 934 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Future health of AYA survivors. Issue 2 (26th October 2018) Authors: Burkart, Madelyn; Sanford, Stacy; Dinner, Shira; Sharp, Lisa; Kinahan, Karen Journal: Pediatric blood & cancer Issue: Volume 66:Issue 2(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Gilteritinib clinical activity in relapsed/refractory FLT3 mutated acute myeloid leukemia previously treated with FLT3 inhibitors. Issue 3 (7th January 2022) Authors: Numan, Yazan; Abdel Rahman, Zaid; Grenet, Justin; Boisclair, Stephanie; Bewersdorf, Jan Philipp; Collins, Cailin; Barth, Dylan; Fraga, Martina; Bixby, Dale L.; Zeidan, Amer M.; Yilmaz, Musa; Desai, Pankil; Mannis, Gabriel; Deutsch, Yehuda E.; Abaza, Yasmin; Dinner, Shira; Frankfurt, Olga; Litzow,... Journal: American journal of hematology Issue: Volume 97:Issue 3(2022) Page Start: 322 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Outcomes of TP53‐mutated AML with evolving frontline therapies: Impact of allogeneic stem cell transplantation on survival. Issue 7 (30th March 2022) Authors: Badar, Talha; Atallah, Ehab; Shallis, Rory M.; Goldberg, Aaron D.; Patel, Anand; Abaza, Yasmin; Bewersdorf, Jan P.; Saliba, Antoine N.; Correia, Guilherme Sacchi De Camargo; Murthy, Guru; Duvall, Adam; Burkart, Madelyn; Stahl, Maximilian; Liu, Yuanhang; Dinner, Shira; Palmisiano, Neil; Litzow, Ma... Journal: American journal of hematology Issue: Volume 97:Issue 7(2022) Page Start: E232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Sequencing of novel agents in relapsed/refractory B‐cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemia. Issue 7 (1st December 2020) Authors: Badar, Talha; Szabo, Aniko; Dinner, Shira; Liedtke, Michaela; Burkart, Madelyn; Shallis, Rory M.; Yurkiewicz, Ilana R.; Kuo, Eric; Khan, Muhammad Ali; Balasubramanian, Suresh; Yang, Jay; Hefazi, Mehrdad; Podoltsev, Nikolai; Patel, Anand; Curran, Emily; Wang, Amy; Arslan, Shukaib; Aldoss, Ibrahim;... Journal: Cancer Issue: Volume 127:Issue 7(2021) Page Start: 1039 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗